Alaunos Therapeutics Regains Nasdaq Equity Compliance
Alaunos Therapeutics said it regained compliance with Nasdaq’s stockholders’ equity requirement, allowing its common stock to remain listed and traded on the Nasdaq Capital Market.
Alaunos Therapeutics said it regained compliance with Nasdaq’s stockholders’ equity requirement, allowing its common stock to remain listed and traded on the Nasdaq Capital Market.